Results 21 to 30 of about 173,135 (267)

APPLICATION OF THE MUSCLE RELAXANT, PANCURONIUM BROMIDE, TO DOGS

open access: bronze, 2010
The muscle relaxant, pancuronium bromide (PB), was examined for effect on dogs with the following results. Muscle relaxation was apparent for 9.2 and 40.0 min.
Akiteru   +9 more
semanticscholar   +3 more sources

PANCURONIUM BROMIDE: AN INDIRECT SYMPATHOMIMETIC AGENT

open access: bronzeBritish Journal of Anaesthesia, 1976
In the dog, pancuronium 0.2 mg/kg increased left ventricular systolic pressure and systemic arterial pressure, but did not change central venous pressure. Repeated doses produced diminishing responses and eventually no change in arterial pressure.
J. M. Rodriguez Sasiain   +4 more
openaire   +4 more sources

Effect of preoperative ivabradine on hemodynamics during elective off-pump CABG. [PDF]

open access: yesAnn Card Anaesth, 2023
Background: Ivabradine is a specific heart rate (HR)-lowering agent which blocks the cardiac pacemaker If channels. It reduces the HR without causing a negative inotropic or lusitropic effect, thus preserving ventricular contractility.
Virmani S   +4 more
europepmc   +2 more sources

Cerebral Blood Flow and Metabolism following Pancuronium Bromide in Newborn Lambs [PDF]

open access: bronzePediatric Research, 1984
J. Belik   +2 more
semanticscholar   +2 more sources

DISPOSITION KINETICS OF PANCURONIUM BROMIDE IN PATIENTS WITH TOTAL BILIARY OBSTRUCTION

open access: bronze, 1977
Plasma concentrations of pancuronium were measured in nine patients undergoing surgery because of total biliary obstruction. When compared with the averaged model-independent pharmacokinetic parameters obtained for normal patients, the terminal half-life
A. Somogyi, E. Triggs, C. Shanks
semanticscholar   +2 more sources

Uptake and Excretion of Vecuronium Bromide and Pancuronium Bromide in the Isolated Perfused Rat Liver [PDF]

open access: bronzeAnesthesiology, 1988
Anton F. Benclni   +6 more
semanticscholar   +2 more sources

Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery [PDF]

open access: yesScripta Medica, 2021
Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings.
Lončar-Stojiljković Dragana
doaj   +1 more source

Home - About - Disclaimer - Privacy